NT
Nutriband Inc.
NTRB · NASDAQ
$5.80 -5.69% (-$0.35)
1M +82.39%
Market Cap $70.5M
P/E Ratio -
Div. Yield -
ROE 109.02%
Bulios Fair Price
$2.95
49.1% downside
Current Price
$5.8
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NTRB is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 13.23x
P/S 43.58x
PEG N/A
Growth
13 /100
Declining Book val. growth 7.98%
Rev. growth 0.69%
FCF growth N/A
Profitability
13 /100
Weak FCF margin 224.55%
Op. margin 435.58%
Gross margin 33.14%
Quality
3 /100
Poor Asset turnover 0.26x
ROA 110.64%
ROIC 127.00%
Debt
69 /100
Low Current ratio 4.21x
Int. coverage -550.70x
Debt/Equity 0.04x
Stability
33 /100
Unstable Profitable years 0
EPS volatility 74.94%
Beta 2.04x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NTRB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gareth Sheridan
Employees
13
Headquarters
Orlando
Upcoming events
07 DEC
Earnings
Upcoming earnings report